Prof. Nils Thoennissen is an international specialist in cancer, chronic degenerative diseases, and regenerative medicine with over 20 years of experience in evidence-based medicine and 14 years of clinical experience in hemotherapy. He has authored 40 scientific publications in peer-reviewed journals and has been awarded 6 awards. He has received postgraduate training at the University of Münster, Cardiff University School of Medicine, University of Mainz, and Cedars-Sinai Medical Center. He currently holds the position of medical director of CBC Health, and has held previous positions as chief physician in St. George Hospital, Kloster Paradies Medical Center, and the University Medical Center Hamburg-Eppendorf.
Accommodation is not included
Transfer airport-clinic-airport
CBC Health is a day-clinic where the patient will get his treatment and will be released every day to the hotel.
Symptoms after a stroke: cord blood and prove their curative effect.
According to statistics, 20 to 25% of patients who survive a stroke die within the following four weeks. All others have various degrees of brain damage, ranging from mild problems in everyday life to severe symptoms requiring long-term care. Is there a way to avoid this? New methods of regenerative therapy suggest that there is.
Umbilical cord blood - therapies and for a better prognosis
As a result of a stroke, there is reactive inflammation in the brain caused by the damaged tissue. Unfortunately, this impairs the patient's recovery process and can also affect adjacent healthy brain tissue.
Here, recent meta-analyses in the field of regenerative medicine from 2022 show that it is possible to optimize prognosis after stroke has occurred (Paton MCB et al, Cytotherapy, 2022). Intravenous delivery of umbilical cord blood (UCB) may lead to improvement in this case, as the primitive cells contained in UCB may help inflammation in the brain to subside more quickly and rescue neurons that are about to die. In addition, UCB provides powerful growth factors and molecules that stimulate natural healing processes such as the formation of new synapses and neuronal circuitry.
While the efficacy of regenerative stem cell therapy has not been fully researched, there are no concerns about unexpected safety risks associated with its use. Most positively, there are no reports of immunological rejection, and UCB has an even lower risk profile than traditional blood transfusion in adults. These findings give stroke patients reason to hope for a better future.
Personal medical coordinator
Medical travel arrangements — booking of air tickets and hotel rooms at special partner prices
Patient advocacy during medical travel